Hudson Bay Capital Management
CTOR

Hudson Bay Capital Management’s Citius Oncology CTOR Stock Holding History

Hudson Bay Capital Management’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-299,300
Closed -$3.39M – 1087
2024
Q2 		$3.39M Hold
299,300
– – 0.02% 447
2024
Q1 		$3.31M Sell
299,300
-200,700
-40% -$2.21M 0.02% 384
2023
Q4 		$5.47M Hold
500,000
– – 0.03% 288
2023
Q3 		$5.38M Hold
500,000
– – 0.04% 269
2023
Q2 		$5.26M Hold
500,000
– – 0.04% 300
2023
Q1 		$5.2M Hold
500,000
– – 0.04% 300
2022
Q4 		$5.08M Buy
+500,000
New +$5.07M 0.05% 349

Other funds holding CTOR

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Hudson Bay Capital Management's CTOR Position: Q3 2024 in Review

Hudson Bay Capital Management sold out of Citius Oncology (CTOR) in Q3 2024, closing a stake of 299,300 shares — an estimated $3.39M sold.

Hudson Bay Capital Management first reported a position in CTOR in Q4 2022 and held it in 7 quarters. The position peaked at $5.47M in Q4 2023. 7 funds tracked by Wall St. Rank hold CTOR as of Q3 2024.

  • Hudson Bay Capital Management reported no remaining Citius Oncology position as of Q3 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 299,300 Citius Oncology shares in Q3 2024, an estimated $3.39M.
  • Hudson Bay Capital Management first reported a position in Citius Oncology in Q4 2022 and held it in 7 quarters.
  • Hudson Bay Capital Management's Citius Oncology position peaked at $5.47M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2024.

Based on Hudson Bay Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.